← All trials
NCT05122780
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2021
- Primary completion
- Jul 31, 2024
- Completion date
- Jul 31, 2024
- First posted
- Nov 17, 2021
- Last posted
- Nov 17, 2021
- Enrollment
- 180
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Universita' Cattolica del Sacro CuoreLead sponsor
- University of MilanOverall official - principal investigator
- University of MilanCollaborator
- Universita' Cattolica del Sacro CuoreReponsible party - principal investigator
- Centro Cardiologico Monzino IRCCSOverall official - principal investigator
- Centro Cardiologico Monzino IRCCSCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.